July 29, 2014 11:45 PM ET

Biotechnology

Company Overview of Vicept Therapeutics Incorporated

Company Overview

Vicept Therapeutics Incorporated, a biopharmaceutical company, focuses on creating products for dermatology markets. Its products include V-101 is a prescription topical formulation for the treatment of the erythema of rosacea; V-102, an actinic purpura solution; and V-103, a peri-procedural bruising solution. Vicept Therapeutics also engages in the development of topical agents for the treatment and prevention of various medical and cosmetic indications, including bruising of the skin. The company was founded in 2009 and is based in Malvern, Pennsylvania. As of July 22, 2011, Vicept Therapeutics Incorporated operates as a subsidiary of Allergan Inc.

101 Lindenwood Drive

Suite 430

Malvern, PA 19355

United States

Founded in 2009

Phone:

484-324-2930

Fax:

484-324-2988

Key Executives for Vicept Therapeutics Incorporated

Chief Executive Officer
Age: 44
Executive Chairman
Co-Founder and Chief Operating officer
Chief Financial Officer
Senior Director of Clinical Operations
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Kineta Prime Inc. United States
Intravascular Medical United States
Aline Biosciences LLC United States
SciGene Corporation United States
Elusys Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vicept Therapeutics Incorporated, please visit www.vicepttx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.